Hypoxia-Induced MicroRNAs Confer Survival Advantage in Bladder Cancer by Fine-Tuning Oncogenic Pathways
Oncology · 07.04.2026 · 1-9
DOI: 10.1159/000551754 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, online erschienen am 07.04.2026. Verfasst von Takaya Ohno und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, MicroRNAs, Hypoxia. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Introduction
Bladder cancer (BC) is influenced by hypoxic conditions, which promote tumor progression and resistance to therapy. MicroRNAs (miRNAs) play key roles in regulating gene expression under hypoxia.
Methods
This study utilized an miRNA array to compare expression profiles under normoxic and hypoxic conditions. We analyzed 1,024 miRNAs, focusing on differentially expressed miRNAs. Survival analysis was performed using a cohort of 408 BC patients from TCGA (The Cancer Genome Atlas). Target prediction for hypoxia-inducible factors (HIFs) and cancer-related genes was performed.
Results
Of 1,024 miRNAs, 508 were downregulated and 516 upregulated in hypoxia. Four miRNAs (hsa-miR-210, hsa-miR-4435, hsa-miR-6875, hsa-miR-193b) were upregulated >50-fold, and four (hsa-miR-1250, hsa-miR-1288, hsa-miR-362, hsa-miR-6828) were downregulated. Upregulated miRNAs were associated with a trend toward improved overall survival in 408 BC patients (log-rank p = 0.049). Three downregulated miRNAs targeted HIF-1α, while three upregulated miRNAs targeted HIF-3α. Hsa-miR-210 targeted AGO2 and USP10, with hsa-miR-4435 also targeting AGO2.
Conclusion
BC under hypoxia exhibits a specific miRNA profile targeting HIFs and cancer-related genes including AGO2 and USP10, potentially influencing treatment success and survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Osaka Medical and Pharmaceutical University, Takatsuki, Japan.
- Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan, t-ina1@hama-med.ac.jp.
Zitieren
APA
Ohno, T., Nakajima, Y., Yoshikawa, Y., Tsujino, T., Maenosono, R., Nakamura, K., Takai, T., Uchimoto, T., Fukushima, T., Nishimura, K., Yano, Y., Higashio, T., Matsunaga, T., Nakamori, K., Azuma, H., & Inamoto, T. (2026). Hypoxia-Induced MicroRNAs Confer Survival Advantage in Bladder Cancer by Fine-Tuning Oncogenic Pathways. Oncology, 1-9. https://doi.org/10.1159/000551754
Vancouver
Ohno T, Nakajima Y, Yoshikawa Y, Tsujino T, Maenosono R, Nakamura K, et al. Hypoxia-Induced MicroRNAs Confer Survival Advantage in Bladder Cancer by Fine-Tuning Oncogenic Pathways. Oncology. 2026:1-9. doi:10.1159/000551754
BibTeX
@article{Ohno2026,
author = {Ohno, Takaya and Nakajima, Yuki and Yoshikawa, Yuki and Tsujino, Takuya and Maenosono, Ryoichi and Nakamura, Ko and Takai, Tomoaki and Uchimoto, Taizo and Fukushima, Tatsuo and Nishimura, Kazuki and Yano, Yusuke and Higashio, Takuya and Matsunaga, Tomohisa and Nakamori, Keita and Azuma, Haruhito and Inamoto, Teruo},
title = {Hypoxia-Induced MicroRNAs Confer Survival Advantage in Bladder Cancer by Fine-Tuning Oncogenic Pathways},
journal = {Oncology},
year = {2026},
pages = {1--9},
doi = {10.1159/000551754}
}
EUVIMED